Sinovac Biotech regulatory approval expanded to include geriatric population
Sinovac Biotech announced that it received a revised production license from State Food and Drug Administration for Panflu.1, the Company's H1N1 vaccine. The population has been expanded to include people over 60 years old. The shelf life for PANFLU.1 was extended to one year from six months. :theflyonthewall.com
News For SVA From The Last 14 Days
Check below for free stories on SVA the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
